6F3V

Backbone structure of bradykinin (BK) peptide bound to human Bradykinin 2 Receptor (B2R) determined by MAS SSNMR

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 13C-13C DQ-SQ	0.36 ug/uL [U-13C, 15N]-F8R9 Bradykinin (BK), 21.4 mg/mL unlabeled hB2R, 50 mM unlabeled HEPES, 100 mM unlabeled NaCl, 2 mM unlabeled EDTA, 4 % w/v unlabeled DDM	100% H2O	125 mM	7.4	1 atm	200	Bruker AVANCE 600
2	2D 13C-13C DQ-SQ	0.36 ug/uL [U-13C, 15N]-P2P3G4F5S6P7F8 Bradykinin (BK), 21.4 mg/mL unlabeled hB2R, 50 mM unlabeled HEPES, 100 mM unlabeled NaCl, 2 mM unlabeled EDTA, 4 % w/v unlabeled DDM	100% H2O	125 mM	7.4	1 atm	200	Bruker AVANCE 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	500
Conformers Submitted Total Number	10
Representative Model	4 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	collection	TopSpin		Bruker Biospin
3	processing	TopSpin		Bruker Biospin
4	chemical shift assignment	TopSpin		Bruker Biospin
6	processing	TopSpin		Bruker Biospin
5	data analysis	TALOS+		Shen, Delaglio, Cornilescu, Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.